Comparative proteomic analysis of astrocytoma tissues from patients with and without seizures
Issued Date
2025-01-24
Resource Type
eISSN
20452322
Scopus ID
2-s2.0-85216717906
Pubmed ID
39849075
Journal Title
Scientific reports
Volume
15
Issue
1
Rights Holder(s)
SCOPUS
Bibliographic Citation
Scientific reports Vol.15 No.1 (2025) , 3020
Suggested Citation
Khaosuwan T., Leetanaporn K., Choochuen P., Navakanitworakul R., Kaewborisutsakul A., Tunthanatip T., Sangkhathat S., Chiangjong W., Phabphal K. Comparative proteomic analysis of astrocytoma tissues from patients with and without seizures. Scientific reports Vol.15 No.1 (2025) , 3020. doi:10.1038/s41598-025-87525-3 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/104267
Title
Comparative proteomic analysis of astrocytoma tissues from patients with and without seizures
Corresponding Author(s)
Other Contributor(s)
Abstract
Astrocytoma is a common type of glioma and a frequent cause of brain tumour-related epilepsy. Although the link between glioma and epilepsy is well established, the precise mechanisms underlying epileptogenesis in astrocytoma remain poorly understood. In this study, we performed proteomic analysis of astrocytoma tissue from patients with and without seizures using mass spectrometry-based techniques. We detected 131 differentially expressed proteins (42 upregulated and 89 downregulated). Proteins upregulated in patients with seizures were mostly related to an increase in energy metabolism. Moreover, glial fibrillary acidic protein, which is involved in maintaining normal axonal structures, was abnormally highly expressed in patients with seizures. Proteins downregulated in patients with seizures included those involved in trans-synaptic signalling and gamma-aminobutyric acid synaptic transmission. Interestingly, comparison of protein expression profiles from our cohort with those from a previous study of patients with epilepsy due to other causes showed that the collapsin response mediator protein family of axonal growth regulators was highly expressed only in patients with seizures due to astrocytomas. Further studies of the proteins identified here are required to determine their potential as biomarkers and therapeutic targets.